Comparative efficacy and safety of anti-HGF/MET pathway agents plus chemotherapy versus chemotherapy alone as first-line treatment in advanced gastric cancer: a protocol for a systematic review and meta-analysis

Comparative efficacy and safety of anti-HGF/MET pathway agents plus chemotherapy versus chemotherapy alone as first-line treatment in advanced gastric cancer: a protocol for a systematic review and meta-analysis

Introduction Phase I/II clinical trials suggested that the hepatocyte growth factor (HGF)/mesenchymal-epithelial transition (MET) pathway-targeted agents were active in suppression of gastric cancer (GC). Randomised controlled trials (RCTs) were undertaken assessing whether the addition of anti-HGF/...

Full description

Saved in:
Bibliographic Details
Main Authors: Chunyu Liu, Bo Zhang, Zhiyuan Jiang, Zhaolun Cai, Yuan Yin, Chaoyong Shen, Qin Ma, Xiaonan Yin, Chen Chang, Zhou Zhao, Mingchun Mu
Format: Article
Language:English
Published: BMJ Publishing Group 2021-12-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/11/12/e049575.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items